Results 91 to 100 of about 2,328 (144)

The Role of QuantiFERON-TB Gold Plus in Mycobacterium Tuberculosis Detection in a Severe HIV Immunocompromised Patient-Case Report. [PDF]

Pathogens, 2021
Dumitrescu F, Pisoschi CG, Pădureanu V, Stoian AC, Dragonu L, Giubelan L.   +5 more
europepmc   +1 more source

Time interval for QuantiFERON-TB Gold Plus conversion after last exposure with tuberculosis. [PDF]

ERJ Open Res
Kyaw WM, Tay JY, Lim LK, Ng DHL.
europepmc   +1 more source

Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients. [PDF]

J Clin Microbiol, 2021
Shier KL.
europepmc   +1 more source

Factors associated with indeterminate QuantiFERON-TB Gold Plus Test results during the COVID-19 pandemic. [PDF]

PLoS One
Román-Montes CM, Tamez-Torres KM, Guaracha-Basañez GA, Ordinola-Navarro A, Ortiz-Bustamante MA, Rajme-López S, Martínez-Guerra BA, Ordaz-Vázquez A, Sifuentes-Osornio J, Ponce-de-León A, González-Lara F, Bobadilla-Del-Valle M.   +11 more
europepmc   +1 more source

QuantiFERON-TB Gold Plus Test in Diagnostics of Latent Tuberculosis Infection in Children Aged 1-14 in a Country with a Low Tuberculosis Incidence. [PDF]

Pol J Microbiol, 2021
Borkowska-Tatar D, Krasińska M, Augustynowicz-Kopeć E.   +2 more
europepmc   +1 more source

Commentary on: diagnostic accuracy and predictive value of the QuantiFERON-TB Gold Plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study. [PDF]

Lancet Reg Health Eur
Allen V, Galloway J.
europepmc   +1 more source

Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study. [PDF]

Lancet Reg Health Eur
Sester M, Altet-Gomez N, Andersen ÅB, Arias-Guillén M, Avsar K, Bakken Kran AM, Bothamley G, Nordholm Breschel AC, Brown J, Chesov D, Ciobanu N, Cirillo DM, Crudu V, de Souza Galvao M, Dilektasli AG, Dominguez J, Duarte R, Dyrhol-Riise AM, Goletti D, Hoffmann H, Ibraim E, Kalsdorf B, Krawczyk M, Kunst H, Lange B, Lipman M, Matteelli A, Milkiewicz P, Neyer D, Nitschke M, Oral HB, Palacios-Gutiérrez JJ, Petruccioli E, Raszeja-Wyszomirska J, Ravn P, Rupp J, Spohn HE, Toader C, Villar-Hernandez R, Wagner D, van Leth F, Martinez L, Pedersen OS, Lange C.   +43 more
europepmc   +1 more source

QuantiFERON-TB Gold plus testing for the detection of LTBI among health care workers in major TB hospitals of the Northern Kyrgyz Republic. [PDF]

BMC Infect Dis, 2022
Corbett C, Kalmambetova G, Umetalieva N, Ahmedov S, Antonenka U, Myrzaliev B, Sahalchyk E, Vogel M, Kadyrov A, Hoffmann H.   +9 more
europepmc   +1 more source

Latent Tuberculosis Infection Status of Pregnant Women in Uganda Determined Using QuantiFERON TB Gold-Plus. [PDF]

Open Forum Infect Dis, 2021
Bongomin F, Ssekamatte P, Nattabi G, Olum R, Ninsiima S, Kyazze AP, Nabakka W, Kukunda R, Cose S, Kibirige D, Batte C, Kaddumukasa M, Kirenga BJ, Nakimuli A, Baluku JB, Andia-Biraro I.   +15 more
europepmc   +1 more source

Correction to Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study Lancet Reg Health Eur 57 (2025) 101416 LLRHEUROPE-D-25-00310. [PDF]

Lancet Reg Health Eur
Sester M, Altet-Gomez N, Andersen ÅB, Arias-Guillén M, Avsar K, Bakken Kran AM, Bothamley G, Nordholm Breschel AC, Brown J, Chesov D, Ciobanu N, Cirillo DM, Crudu V, de Souza Galvao M, Dilektasli AG, Dominguez J, Duarte R, Dyrhol-Riise AM, Goletti D, Hoffmann H, Ibraim E, Kalsdorf B, Krawczyk M, Kunst H, Lange B, Lipman M, Matteelli A, Milkiewicz P, Neyer D, Nitschke M, Oral HB, Palacios-Gutiérrez JJ, Petruccioli E, Raszeja-Wyszomirska J, Ravn P, Rupp J, Spohn HE, Toader C, Villar-Hernandez R, Wagner D, van Leth F, Martinez L, Pedersen OS, Lange C.   +43 more
europepmc   +1 more source